Tealwood Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.6M | Sell |
3,192
-4
| -0.1% | -$1.92K | 0.61% | 82 |
|
|
2026
Q1 | $1.57M | Buy |
3,196
+41
| +1% | +$22.3K | 0.71% | 72 |
|
|
2025
Q4 | $1.83M | Sell |
3,155
-22
| -0.7% | -$12.4K | 0.82% | 54 |
|
|
2025
Q3 | $1.54M | Sell |
3,177
-82
| -3% | -$38.2K | 0.62% | 82 |
|
|
2025
Q2 | $1.32M | Buy |
3,259
+821
| +34% | +$343K | 0.59% | 91 |
|
|
2025
Q1 | $1.21M | Sell |
2,438
-13
| -0.5% | -$7.04K | 0.56% | 91 |
|
|
2024
Q4 | $1.27M | Sell |
2,451
-70
| -3% | -$38.5K | 0.53% | 93 |
|
|
2024
Q3 | $1.56M | Buy |
+2,521
| New | +$1.49M | 0.68% | 71 |
|
|
2024
Q2 | – | Sell |
-2,493
| Closed | -$1.45M | – | 118 |
|
|
2024
Q1 | $1.45M | Buy |
2,493
+37
| +2% | +$20.8K | 0.65% | 75 |
|
|
2023
Q4 | $1.3M | Sell |
2,456
-14
| -0.6% | -$6.78K | 0.62% | 79 |
|
|
2023
Q3 | $1.25M | Buy |
2,470
+54
| +2% | +$28.8K | 0.64% | 76 |
|
|
2023
Q2 | $1.26M | Sell |
2,416
-3
| -0.1% | -$1.62K | 0.61% | 79 |
|
|
2023
Q1 | $1.39M | Sell |
2,419
-76
| -3% | -$42.8K | 0.71% | 57 |
|
|
2022
Q4 | $1.37M | Sell |
2,495
-125
| -5% | -$66.2K | 0.72% | 60 |
|
|
2022
Q3 | $1.33M | Buy |
2,620
+2
| +0.1% | +$1.12K | 0.72% | 53 |
|
|
2022
Q2 | $1.42M | Sell |
2,618
-18
| -0.7% | -$9.91K | 0.71% | 50 |
|
|
2022
Q1 | $1.56M | Sell |
2,636
-103
| -4% | -$59.2K | 0.66% | 59 |
|
|
2021
Q4 | $1.83M | Sell |
2,739
-157
| -5% | -$98K | 0.73% | 48 |
|
|
2021
Q3 | $1.65M | Buy |
+2,896
| New | +$1.59M | 0.67% | 53 |
|
|
2021
Q1 | $1.29M | Sell |
2,832
-4
| -0.1% | -$1.91K | 0.52% | 97 |
|
|
2020
Q4 | $1.32M | Sell |
2,836
-180
| -6% | -$84.4K | 0.62% | 74 |
|
|
2020
Q3 | $1.33M | Sell |
3,016
-16
| -0.5% | -$6.61K | 0.87% | 44 |
|
|
2020
Q2 | $1.1M | Sell |
3,032
-3,897
| -56% | -$1.31M | 0.73% | 50 |
|
|
2020
Q1 | $1.97M | Buy |
6,929
+2
| +0% | +$631 | 1.12% | 46 |
|
|
2019
Q4 | $2.25M | Sell |
6,927
-103
| -1% | -$31.2K | 0.94% | 62 |
|
|
2019
Q3 | $2.05M | Sell |
7,030
-1,576
| -18% | -$451K | 0.88% | 69 |
|
|
2019
Q2 | $2.53M | Sell |
8,606
-74
| -0.9% | -$20.4K | 1.03% | 52 |
|
|
2019
Q1 | $2.38M | Sell |
8,680
-545
| -6% | -$136K | 1.01% | 50 |
|
|
2018
Q4 | $2.06M | Sell |
9,225
-334
| -3% | -$78.4K | 0.98% | 48 |
|
|
2018
Q3 | $2.33M | Sell |
9,559
-434
| -4% | -$99.8K | 0.87% | 57 |
|
|
2018
Q2 | $2.07M | Sell |
9,993
-1,147
| -10% | -$243K | 0.81% | 61 |
|
|
2018
Q1 | $2.3M | Sell |
11,140
-10
| -0.1% | -$2.1K | 0.91% | 47 |
|
|
2017
Q4 | $2.12M | Buy |
11,150
+585
| +6% | +$112K | 0.78% | 53 |
|
|
2017
Q3 | $2M | Sell |
10,565
-60
| -0.6% | -$10.9K | 0.72% | 60 |
|
|
2017
Q2 | $1.85M | Buy |
10,625
+193
| +2% | +$32.4K | 0.69% | 63 |
|
|
2017
Q1 | $1.6M | Buy |
10,432
+746
| +8% | +$114K | 0.63% | 71 |
|
|
2016
Q4 | $1.37M | Sell |
9,686
-122
| -1% | -$18K | 0.57% | 72 |
|
|
2016
Q3 | $1.56M | Buy |
+9,808
| New | +$1.51M | 0.69% | 64 |
|
Other funds holding TMO
RG
ECSS
LT
Tealwood Asset Management's TMO Position: Q2 2026 in Review
Tealwood Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 0.13% in Q2 2026, selling an estimated $1.92K and leaving 3,192 shares worth $1.6M. The position accounts for 0.61% of the portfolio, ranked #82.
Tealwood Asset Management first reported a position in TMO in Q3 2016 and has held it in 38 quarters since. The position peaked at $2.53M in Q2 2019. 1,170 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Tealwood Asset Management held 3,192 shares of Thermo Fisher Scientific worth $1.6M as of Q2 2026.
- Tealwood Asset Management sold 4 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.92K.
- Thermo Fisher Scientific made up 0.61% of Tealwood Asset Management's portfolio in Q2 2026, its #82 holding.
- Tealwood Asset Management first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 38 quarters since.
- Tealwood Asset Management's Thermo Fisher Scientific position peaked at $2.53M in Q2 2019.
- 1,170 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Tealwood Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.